David Larsen
Stock Analyst at BTIG
(2.70)
# 2,106
Out of 5,012 analysts
78
Total ratings
34.92%
Success rate
0.84%
Average return
Main Sectors:
Stocks Rated by David Larsen
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| EVH Evolent Health | Reiterates: Buy | $20 | $8.12 | +146.31% | 6 | Sep 30, 2025 | |
| CYRX Cryoport | Maintains: Buy | $10 → $15 | $10.03 | +49.55% | 4 | Sep 18, 2025 | |
| HCAT Health Catalyst | Reiterates: Neutral | n/a | $2.80 | - | 4 | Sep 5, 2025 | |
| VEEV Veeva Systems | Maintains: Buy | $335 → $340 | $298.17 | +14.03% | 2 | Aug 28, 2025 | |
| SLP Simulations Plus | Maintains: Buy | $41 → $25 | $15.69 | +59.34% | 3 | Jul 7, 2025 | |
| DOCS Doximity | Upgrades: Buy | $80 | $72.43 | +10.45% | 2 | Jun 2, 2025 | |
| PGNY Progyny | Upgrades: Buy | $28 | $20.58 | +36.05% | 4 | Mar 31, 2025 | |
| HIMS Hims & Hers Health | Initiates: Buy | $35 | $58.05 | -39.71% | 1 | Jan 7, 2025 | |
| HQY HealthEquity | Maintains: Buy | $110 → $130 | $92.82 | +40.06% | 4 | Nov 14, 2024 | |
| CCSI Consensus Cloud Solutions | Maintains: Buy | $30 → $31 | $26.40 | +17.42% | 3 | Nov 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $290 → $260 | $202.05 | +28.68% | 2 | Nov 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $15 → $20 | $28.54 | -29.92% | 2 | Oct 3, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $60 → $70 | $30.23 | +131.56% | 1 | Oct 3, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $7 | $3.12 | +124.36% | 1 | Sep 17, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $11 → $7 | $1.20 | +485.77% | 4 | May 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $13 → $14 | $6.47 | +116.55% | 3 | Apr 23, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $9.20 | - | 2 | Apr 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $31.19 | - | 7 | Nov 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | n/a | $1.02 | - | 1 | Jun 24, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $35 | $24.30 | +44.03% | 1 | Apr 28, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $8.75 | - | 3 | Nov 22, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | n/a | $6.19 | - | 1 | Jan 7, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Market Perform | n/a | $157.74 | - | 6 | Nov 16, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Market Perform | $170 → $160 | $755.98 | -78.84% | 2 | May 29, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Outperform | n/a | $64.59 | - | 5 | Apr 4, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $90 → $85 | $76.63 | +10.92% | 3 | Feb 9, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Market Perform | $34 → $23 | $4.62 | +397.84% | 1 | Nov 2, 2017 |
Evolent Health
Sep 30, 2025
Reiterates: Buy
Price Target: $20
Current: $8.12
Upside: +146.31%
Cryoport
Sep 18, 2025
Maintains: Buy
Price Target: $10 → $15
Current: $10.03
Upside: +49.55%
Health Catalyst
Sep 5, 2025
Reiterates: Neutral
Price Target: n/a
Current: $2.80
Upside: -
Veeva Systems
Aug 28, 2025
Maintains: Buy
Price Target: $335 → $340
Current: $298.17
Upside: +14.03%
Simulations Plus
Jul 7, 2025
Maintains: Buy
Price Target: $41 → $25
Current: $15.69
Upside: +59.34%
Doximity
Jun 2, 2025
Upgrades: Buy
Price Target: $80
Current: $72.43
Upside: +10.45%
Progyny
Mar 31, 2025
Upgrades: Buy
Price Target: $28
Current: $20.58
Upside: +36.05%
Hims & Hers Health
Jan 7, 2025
Initiates: Buy
Price Target: $35
Current: $58.05
Upside: -39.71%
HealthEquity
Nov 14, 2024
Maintains: Buy
Price Target: $110 → $130
Current: $92.82
Upside: +40.06%
Consensus Cloud Solutions
Nov 11, 2024
Maintains: Buy
Price Target: $30 → $31
Current: $26.40
Upside: +17.42%
Nov 1, 2024
Maintains: Buy
Price Target: $290 → $260
Current: $202.05
Upside: +28.68%
Oct 3, 2024
Maintains: Buy
Price Target: $15 → $20
Current: $28.54
Upside: -29.92%
Oct 3, 2024
Maintains: Buy
Price Target: $60 → $70
Current: $30.23
Upside: +131.56%
Sep 17, 2024
Initiates: Buy
Price Target: $7
Current: $3.12
Upside: +124.36%
May 9, 2024
Maintains: Buy
Price Target: $11 → $7
Current: $1.20
Upside: +485.77%
Apr 23, 2024
Maintains: Buy
Price Target: $13 → $14
Current: $6.47
Upside: +116.55%
Apr 1, 2024
Downgrades: Neutral
Price Target: n/a
Current: $9.20
Upside: -
Nov 3, 2023
Downgrades: Neutral
Price Target: n/a
Current: $31.19
Upside: -
Jun 24, 2022
Initiates: Neutral
Price Target: n/a
Current: $1.02
Upside: -
Apr 28, 2022
Initiates: Buy
Price Target: $35
Current: $24.30
Upside: +44.03%
Nov 22, 2021
Downgrades: Neutral
Price Target: n/a
Current: $8.75
Upside: -
Jan 7, 2021
Initiates: Neutral
Price Target: n/a
Current: $6.19
Upside: -
Nov 16, 2018
Downgrades: Market Perform
Price Target: n/a
Current: $157.74
Upside: -
May 29, 2018
Maintains: Market Perform
Price Target: $170 → $160
Current: $755.98
Upside: -78.84%
Apr 4, 2018
Upgrades: Outperform
Price Target: n/a
Current: $64.59
Upside: -
Feb 9, 2018
Maintains: Outperform
Price Target: $90 → $85
Current: $76.63
Upside: +10.92%
Nov 2, 2017
Maintains: Market Perform
Price Target: $34 → $23
Current: $4.62
Upside: +397.84%